Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Neomycin sulfate

Neomycin sulfate

pharmaceutical raw materials
Neomycin sulfate structure

Neomycin sulfate 

structure
  • CAS No:

    1405-10-3

  • Formula:

    H2O4S.xUnspecified

  • Chemical Name:

    Neomycin sulfate

  • Synonyms:

    Neomycin,sulfate (salt);Lidamycin Creme;Mycifradin N;Myciguent;Neo-Mantle Creme;Neomycin sulphate;Otobiotic;Quintess-N;Neomycin sulfate;Neolate;Neomix;Fradiomycin sulfate;Neofracin;Bykomycin;Mycerin sulfate;Mycifradin;New France F;Neobrettin;Endomixin;Neosulf;Nivemycin;Myacine;Biosol;Tuttomycin;Neo-rx;124847-89-8;125863-87-8;126663-40-9;126683-25-8;127085-47-6;1339-25-9;8013-33-0;8057-38-3;12710-33-7;37318-28-8;56571-68-7;57866-39-4;60799-77-1;63626-34-6

  • Categories:

    Active Pharmaceutical Ingredients  >  Antibiotics

Description

Neomycin sulfate is an aminoglycoside antibiotic used for preventing or treating bacterial infections.

Neomycin sulfate Basic Attributes

712.72200

712.28000

223-969-3

156885

DTXSID4041074

2941909000

Characteristics

436.09000

-4.26550

Tan powder.

>187°C (dec.)

1046.1ºC at 760 mmHg

586.5ºC

56 ° (C=10, H2O)

H2O: 50 mg/mL As a stock solution. Stock solutions should be filter sterilized and stored at 2-8°C. Stable at 37°C for 5 days.

2-8ºC

0mmHg at 25°C

Safety Information

NONH for all modes of transport

3

R42/43

S23; S36/37; S45; S22; S36; S24/25

QP4375000

Xn

Stable. Incompatible with strong oxidizing agents.

P261-P280-P342 + P311

H317-H334

|Danger|H317 (99.15%): May cause an allergic skin reaction [Warning Sensitization, Skin]|P201, P202, P260, P261, P271, P272, P273, P280, P281, P285, P302+P352, P304+P340, P304+P341, P308+P313, P312, P314, P321, P333+P313, P342+P311, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 355 companies from 25 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Neomycin sulfate Use and Manufacturing

Uses

NEOMYCIN SULFATE is an aminoglycoside antibiotic produced by S. fradiae that inhibits protein translation by binding to the small subunit of prokaryotic ribosomes. It blocks voltage-sensitive Ca2+ channels and is a potent inhibitor of skeletal muscle sarcoplasmic reticulum Ca2+ release. NEOMYCIN SULFATE has been shown to inhibit inositol phospholipid turnover, phospholipase C, and phosphatidylcholine-phospholipase D activity (IC50 = 65 μM). It is highly effective against Gram-positive and Gram-negative bacteria and is commonly used for the prevention of bacterial contamination of cell cultures.

Neomycin, sulfate (salt): ACTIVE

Veterinary Drug -> ANTIMICROBIAL_AGENT;

Computed Properties

Molecular Weight:712.7
Hydrogen Bond Donor Count:15
Hydrogen Bond Acceptor Count:23
Rotatable Bond Count:9
Exact Mass:712.27966526
Monoisotopic Mass:712.27966526
Topological Polar Surface Area:436
Heavy Atom Count:47
Complexity:953
Undefined Atom Stereocenter Count:19
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Price Analysis

Make your Neomycin sulfate purchase based on the price and market insights! ECHEMI provides professional market insights with prices for you to make a better choice. Learn more on Neomycin sulfate prices .

Drug Function and Efficacy

It has antibacterial effects on Staphylococcus (methicillin-sensitive strains), Corynebacterium, etc.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • HUASHU PHARMACEUTICAL CORP

    United States United States
    Active
  • Zhejiang Fonow Medicine Co., Ltd.

    China China
    Active
  • Yichang Sanxia Pharmaceutical Co., Ltd.

    European Union European Union
    Active

Recommended Suppliers of Neomycin sulfate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.